EDGAR·FLOW

Most material SEC filings — November 20, 2026

50 filings analyzed. Top movers: IT TECH PACKAGING, INC., Biofrontera Inc., NextCure, Inc., Scilex Holding Co, Tempest Therapeutics, Inc..
8-K IT TECH PACKAGING, INC.
IT Tech Packaging received a going concern opinion from auditor Audit Alliance LLP on its FY2025 10-K (filed November 19, 2026). The company reported a net loss of $24,292,921 and operating cash outflow of $5,350,692 for fiscal year ended December 31, 2025. The auditor's explanatory paragraph states substantial doubt exists about the company's ability to continue as a going concern.
▼ Likely negative · significance 95 · 8-K Agent
8-K Biofrontera Inc.
Biofrontera Inc. filed an 8-K on November 20, 2026 (reporting period November 16, 2026) disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The filing provides no specific details regarding which exchange, which listing standards were violated, remediation plans, or timeline for delisting. No dollar amounts, counterparties, or quantitative metrics are disclosed in this extract.
▼ Likely negative · significance 95 · 8-K Agent
8-K NextCure, Inc.
NextCure, Inc. received notice of failure to satisfy continued listing standards (Item 3.01). The company is a small-cap biotech ($12.6M market value) with no specific details provided in this filing regarding remediation timeline, specific non-compliance rule violated, or required actions. The filing is dated November 20, 2026, with period of report November 16, 2026.
▼ Likely negative · significance 92 · 8-K Agent
8-K Scilex Holding Co
On November 17, 2026, Scilex Holding Co received notice of delisting or failure to satisfy continued listing standards. The 8-K filing reports Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard). No specific cure period, exchange, reason, or remediation plan is detailed in the available filing header.
▼ Likely negative · significance 92 · 8-K Agent
8-K Tempest Therapeutics, Inc.
On November 17, 2026, Tempest Therapeutics received notice of failure to satisfy continued listing standards, triggering Item 3.01 delisting disclosure. No specific listing rule violation, cure period, or remediation plan is detailed in the filing text provided. The company's public market capitalization is approximately $30.1M.
▼ Likely negative · significance 92 · 8-K Agent
8-K Phio Pharmaceuticals Corp.
On November 16, 2026, Phio Pharmaceuticals Corp. received notice of failure to satisfy continued listing standards and faces delisting or transfer of listing. The filing provides no specific financial metrics, compliance violations, or remediation details. For a company with $11.2M market value, delisting represents an existential threat to its ability to raise capital and operate as a public company.
▼ Likely negative · significance 92 · 8-K Agent
8-K URBAN ONE, INC.
On November 17, 2026, Urban One received notice of failure to satisfy continued listing standards, triggering a delisting or transfer of listing. The filing indicates Item 3.01 (delisting notice) and Item 9.01 (financial exhibits) were disclosed. No specific financial metrics, remediation timeline, or exchange details are provided in the available filing text.
▼ Likely negative · significance 92 · 8-K Agent
8-K SeaStar Medical Holding Corp
SeaStar Medical Holding Corp (market cap ~$7.3M) filed an 8-K on November 20, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing indicates the company has failed to meet continued listing standards and faces potential transfer of listing or delisting. No specific dollar amounts, remediation plans, or timeline details are provided in the available filing header.
▼ Likely negative · significance 92 · 8-K Agent
F-1 Tactical Resources Corp.
Tactical Resources Corp. (total assets ~$549K) filed Form F-1 registering 16,549,946 common shares: 2.35M for warrant exercise (Plum Acquisition Corp. III IPO), 4.20M for resale by existing securityholders, and 10M for resale by YA II PN, LTD. (Yorkville Advisors) under a standby equity purchase agreement (SEPA). The Yorkville tranche represents a financing mechanism to issue up to 10M shares to Yorkville. No dollar amounts, pricing, or exercise prices are disclosed in this legal opinion exhibit. The company shows going-concern warnings from auditors (Manning Elliott LLP).
▲ Likely positive · significance 92 · Registration Agent
8-K Presidio Property Trust, Inc.
On November 18, 2026, Presidio Property Trust received notice of delisting or failure to satisfy a continued listing rule or standard, with potential transfer of listing. The filing does not specify which exchange, which listing standard was violated, remediation timeline, or any financial impact figures. No counterparties, dollar amounts, or specific operational changes are detailed.
▼ Likely negative · significance 92 · 8-K Agent
8-K iBio, Inc.
On November 19, 2026, iBio, Inc. received notice of delisting or failure to satisfy a continued listing rule or standard, with a potential transfer of listing. The filing does not specify which exchange, the exact rule violated, cure period, or remedial actions. No dollar amounts, timelines, or specific regulatory details are disclosed.
▼ Likely negative · significance 92 · 8-K Agent
8-K 60 DEGREES PHARMACEUTICALS, INC.
On 2026-11-19, 60 Degrees Pharmaceuticals received notice of failure to satisfy continued listing standards (Item 3.01). The specific listing rule violation, cure period, and any transfer of listing details are not disclosed in the filing header or accessible document summary provided. The company's market capitalization is approximately $3.3M.
▼ Likely negative · significance 92 · 8-K Agent
8-K Ainos, Inc.
On November 18, 2026, Ainos, Inc. (market cap ~$4.4M) received notice of delisting or failure to satisfy continued listing standards. The 8-K filing on November 20, 2026 reports Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard). No specific details regarding remediation timeline, listing standard violated, or exchange name are disclosed in the available text.
▼ Likely negative · significance 92 · 8-K Agent
8-K VisionWave Holdings, Inc.
VisionWave (market cap $24.1M) signed three agreements on November 18, 2026: (1) MoreSpeed forensic video search ($4M unsecured note, due year 1, non-contingent); (2) CMIP critical minerals platform ($11M unsecured note, $5.5M each year 1–2, contingent on $500K revenue in first 3 months and $1M in next 3 months post-closing); (3) engagement with DNE International for advisory services ($3.8M unsecured note, $1.9M each at 6 and 12 months, contingent on CMIP revenue milestone). Total deferred consideration: $18.8M—78% of company market value. All notes are unsecured, subordinated, and non-negotiable. Closing conditions for CMIP include independent valuation. Seller representations include IP ownership, no infringement, no copyleft licenses, and sanctions/trade-control compliance.
▲ Likely positive · significance 82 · 8-K Agent
8-K CENTURY CASINOS INC /CO/
On November 18, 2026, Century Casinos Inc received a notice of delisting or failure to satisfy continued listing standards. The 8-K filing indicates Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) was triggered, though the specific listing rule violation, exchange, remediation timeline, and detailed circumstances are not disclosed in the available document excerpts.
▼ Likely negative · significance 82 · 8-K Agent
4 KNOT Offshore Partners LP
Director Seglem Trygve (KNOP) bought 2.8M shares (~$34.9M) on the open market (18% of holdings). Open-market insider purchase — historically a bullish signal.
▲ Likely positive · significance 78 · Insider Agent
8-K Compass Therapeutics, Inc.
On November 19, 2026, Compass Therapeutics received notice of failure to satisfy continued listing standards (Item 3.01). The filing does not specify which exchange issued the notice, the specific listing rule violated, or remediation timeline. This is a material corporate governance event for the $277M market-cap company.
▼ Likely negative · significance 78 · 8-K Agent
8-K/A Copley Acquisition Corp
Copley Acquisition Corp shareholders approved extending the business combination deadline from November 2, 2026 to November 2, 2027 (12 one-month extensions at $200k each). The sponsor (Copley Acquisition Sponsors, LLC) provided a $2.4M unsecured promissory note to fund extensions. However, 12.9M Class A shares (74.8% of outstanding) were redeemed for ~$137.1M at $10.63/share, leaving only $46.2M in the trust account and 4.35M shares outstanding—a devastating capital impairment that severely constrains the company's ability to complete a business combination.
▼ Likely negative · significance 78 · 8-K Agent
S-1/A BIO KEY INTERNATIONAL INC
Bush Associates CPA LLC consented to incorporate its June 12, 2026 audit report into BIO-key's S-1/A filing. The audit report explicitly includes an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern for the year ended December 31, 2025. This going-concern qualification is a material red flag for investor viability.
▼ Likely negative · significance 78 · Registration Agent
4 New Fortress Energy Inc.
10% owner King Street Capital Management GP, L.L.C. (NFE) bought 60K shares (~$17.7M) on the open market (14% of holdings). Open-market insider purchase — historically a bullish signal.
▲ Likely positive · significance 78 · Insider Agent
SCHEDULE 13D SRX Global Inc.
Kevin Egan and Lee Kiewiet entered into a group agreement (dated November 19, 2026) to coordinate activities regarding SRX Global Inc. securities. Combined purchases from September 23 through November 17, 2026 total approximately 397,000 shares at prices ranging from $0.79 to $1.78 per share, representing ~$390k aggregate spend. Egan retains control over group expenses, SEC filings, and communications; Kiewiet is restricted from selling prior to the next annual meeting without Egan's consent.
▲ Likely positive · significance 76 · Ownership Agent
8-K VenHub Global, Inc.
VenHub Global, Inc. issued a convertible promissory note to Meridian Equity Ventures, LLC dated November 17, 2026, with principal amount up to $2,000,000 funded in four equal $500,000 tranches over four months. The note bears 5% annual interest (10% during default), matures March 16, 2027, and converts to common stock at 90% of average VWAP with a floor price of $0.0414 per share. Conversion is subject to Nasdaq's 19.99% exchange cap and a 9.99% beneficial ownership limit for the holder.
▼ Likely negative · significance 76 · 8-K Agent
8-K Aether Holdings, Inc.
Aether Holdings signed a binding tripartite framework agreement dated November 18, 2026 with Cho Thavee Public Company Limited (CHO) and Advance Capital Partners Limited (ACP) to develop an AI data center in Khon Kaen, Thailand. Under the deal, Aether receives 5% of CHO on a fully diluted basis unconditionally; Aether and CHO each hold 47.5% of the joint venture (AAC Compute Co., Ltd.) with ACP holding 5%; CHO contributes a ~14-acre factory site with 0.85 MW existing power capacity via below-market long-term leases and purchase options; Aether contributes technology expertise and platform licensing; the JV bears all capital and operating expenses with no obligation for Aether to fund absent separate written commitment. Key conditions precedent include CHO stock trading resumption, execution of definitive agreements, site lease/purchase option registration, environmental/technical due diligence, and financing commitments.
▲ Likely positive · significance 72 · 8-K Agent
8-K Translational Development Acquisition Corp.
On November 16, 2026, Translational Development Acquisition Corp. (TDAC, $177.7M market cap) and Prologium Holding Inc. executed a First Amendment to their May 27, 2026 merger agreement. Key changes: Equity Value fixed at $3.9B enterprise value ($3.8B plus $100M net cash); Aggregate Company Shares set at 93.68M (89.44M pre-recapitalization shares plus 2.58M warrant shares plus 1.66M reserved options); Consolidation Factor set at 4.16; dispute resolution moved from HKIAC to Singapore International Arbitration Centre (SIAC); Post-Closing Board structured with 9 directors including 1 TDAC designee, 3 Founder designees, plus appointment rights for SBCVC Shareholder, New Epoch Capital LP, and New Horizon I. Recapitalization creates Class A, B, C ordinary shares with differential voting/ownership. No dollar amounts for PIPE investment specified.
▲ Likely positive · significance 72 · 8-K Agent
8-K Aprea Therapeutics, Inc.
Aprea announced interim Phase 1 results for APR-1051 (WEE1 inhibitor) in 56 patients with advanced solid tumors as of November 1, 2026. Key findings: 1 confirmed partial response (PR) and 1 unconfirmed PR in PPP2R1A-mutated uterine cancer patients; 5 patients with stable disease >4 months; 84% of evaluable patients (21/25) showed ≥50% reduction in pCDK1-Y15 (WEE1 target engagement); 1 dose-limiting toxicity (liver enzyme elevation at 50mg); predominantly Grade 1-2 adverse events. Company plans to enroll ≥50 additional patients in focused cohorts (uterine serous carcinoma and cyclin E-overexpressing platinum-resistant ovarian cancer), with dose escalation completion expected Q2 2027.
▲ Likely positive · significance 72 · 8-K Agent
8-K BILL Holdings, Inc.
Blizzard Borrower 2026, Inc. (backed by TPG and Corpay) agreed to acquire BILL Holdings for $63.25 per share in an all-cash merger. The deal values BILL at approximately $5.44 billion (86.0M shares × $63.25), representing a ~32% premium from recent trading. Financing is committed via equity and debt sources; transaction expected to close in early 2027 subject to shareholder and regulatory approvals.
▲ Likely positive · significance 72 · 8-K Agent
8-K My Size, Inc.
MySize (market cap ~$4.0M) posted nine-month 2026 revenue of $7.32M (+21% YoY) but Q3 revenue fell 28% to $1.86M due to Amazon inventory constraints. The company completed a $2.5M private placement (net $2.12M) in September and cut Naiz Fit workforce by ~50%, targeting $793K annualized savings. Management warns existing cash ($2.41M) will fund operations for less than 12 months, triggering going-concern doubt; the company is evaluating defense-technology acquisitions as strategic diversification but has no experience in that sector.
▼ Likely negative · significance 72 · 8-K Agent
8-K EXICURE, INC.
On November 19, 2026, Exicure entered into a Strategic Business Expansion and Investment Agreement with NeuroQ Biologics Inc. and Laonz Co., Ltd. to acquire an equity interest (20–100%, exact percentage and share exchange ratio to be determined) in NeuroQ and provide up to $500,000 in development funding. NeuroQ acquired the X-CUE augmented-reality smart-glasses technology (targeting Parkinson's freezing-of-gait) from Laonz and will lead clinical evaluation (anticipated ~6 months) and commercialization, with Exicure providing strategic support.
▲ Likely positive · significance 72 · 8-K Agent
8-K Boxlight Corp
Boxlight's Form S-1 registration statement became effective on November 18, 2026, clearing the path for $2.0M in gross proceeds from the second tranche of Series D Preferred Stock financing (bringing total Series D to $7.5M) and enabling use of a $15M equity line of credit. However, on the same date, Nasdaq notified the company that stockholders' equity of $1.9M (as of September 30, 2026) falls below the $2.5M minimum requirement; the company received a delisting determination and plans to request a hearing before the Nasdaq Hearings Panel by November 25, 2026, with trading to continue pending the Panel's decision. Proceeds will be used to reduce debt with WhiteHawk Finance LLC and for working capital.
▲ Likely positive · significance 72 · 8-K Agent
10-Q Vivakor, Inc.
Vivakor retained Leslie D. Patterson, its former EVP/COO (resigned Sept 24, 2026), as an independent consultant effective Oct 29, 2026 for one year. Compensation: $20,000 in common stock per month (valued at 5-day VWAP) for ≥10 hours/week of operational services; quarterly true-up if proceeds from share sales <90% of compensation value. Shares capped at 4.99% beneficial ownership (movable to 9.99% with 61-day notice) and cannot exceed 19.99% of outstanding shares without shareholder approval. Services cover asset management, field operations, compliance, stakeholder coordination, and transition support. Agreement terminable by either party on 10 days' notice.
— Neutral · significance 72 · Periodic Agent
8-K TAKE TWO INTERACTIVE SOFTWARE INC
Grand Theft Auto VI achieved $3.79 billion in day-one retail sales (November 19, 2026) and sold 32.5 million units pre-release, both claimed as all-time records. The game received a Metacritic score of 99. No specific guidance, revenue guidance revision, or financial impact projections are provided in this press release.
▲ Likely positive · significance 72 · 8-K Agent
8-K Enphase Energy, Inc.
CEO announces restructuring affecting approximately 320 employees (~9% of workforce based on typical company size) due to 35% YoY U.S. sell-through decline following expiration of 25D tax credit and weak European demand. Non-GAAP operating expenses targeted to drop from ~$80M to $60-65M per quarter starting Q1 2027, with one-time restructuring charges of $25-28M. Severance includes minimum 13 weeks pay and accelerated RSU vesting in U.S.; company refocusing on five growth drivers.
▼ Likely negative · significance 72 · 8-K Agent
8-K PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals reported Phase 2 PYNNACLE trial data for rezatapopt (PC14586), a p53 reactivator targeting TP53 Y220C mutations: 48% confirmed ORR (31/65 patients) with 10.4-month median duration of response in platinum-resistant/refractory ovarian cancer; 36% ORR (61/168 patients) across all 168 evaluable patients in eight tumor types. Safety profile remained manageable with mostly Grade 1-2 adverse events; 6% (11/180) discontinued due to treatment-related adverse events. Company plans NDA submission for accelerated approval in Q1 2027.
▲ Likely positive · significance 72 · 8-K Agent
8-K Arrive AI Inc.
Arrive AI completed three transactions since September 30, 2026 totaling approximately $5.5M in equity raises and debt relief: (1) private placement of $250K on October 5, 2026; (2) At-The-Market (ATM) sales of $1.3M; and (3) Streeterville Capital debt-for-preferred-stock exchange removing ~$4.0M in liabilities. Pro forma stockholders equity reached $7.7M, exceeding the $2.5M Nasdaq Capital Market minimum requirement under Rule 5550(b)(1). The company's actual reported equity was $2.2M as of September 30, 2026.
▲ Likely positive · significance 72 · 8-K Agent
8-K Acrivon Therapeutics, Inc.
Acrivon presented Phase 1/2 dose-escalation results for ACR-2316, a first-in-class oral WEE1/PKMYT1 inhibitor, in 33 patients with advanced solid tumors. Safety was favorable: Grade ≥3 treatment-related adverse events were predominantly transient, mechanism-based neutropenia/leukopenia (45.5% of patients); no Grade 5 events or non-hematologic dose-limiting toxicities; 120 mg and 160 mg (3 days on/4 days off) selected for expansion. Clinical activity included 1 confirmed complete response (squamous NSCLC, 65 weeks on study), 1 confirmed partial response (endometrial, 40 weeks), 1 unconfirmed PR with 69% shrinkage (SCLC), and 3 stable diseases in lung cancer patients (up to 71 weeks).
▲ Likely positive · significance 72 · 8-K Agent
8-K Wheeler Real Estate Investment Trust, Inc.
On 2026-11-20, Wheeler Real Estate Investment Trust filed an 8-K disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), along with an unregistered equity sale (Item 3.02). No specific counterparty names, dollar amounts, percentages, share counts, or transaction terms are disclosed in the filing header or accessible document list provided.
— Neutral · significance 72 · 8-K Agent
S-1 Aptevo Therapeutics Inc.
Aptevo issued 13,888,890 Inducement Warrants on November 11, 2026 to three warrant holders (Armistice Capital, Hudson Bay, Sabby Volatility) at $1.08/share exercise price in exchange for immediate cash exercise of 2,777,778 existing warrants at reduced $1.08 price. The company received ~$3.0M gross proceeds from warrant exercise; if Inducement Warrants are exercised in full, company would receive ~$15.0M additional. Resale shares represent 79% of post-offering outstanding shares (13.9M of 17.5M total). Stock price on November 19, 2026: $0.41/share. This is a shelf registration for resale of warrant-exercise shares.
▼ Likely negative · significance 72 · Registration Agent
8-K Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts has filed its definitive proxy statement for the December 21, 2026 annual meeting and appointed seven new independent directors to replace the legacy board, alongside CEO Richard Stockton. The company has completed its transition to a self-managed REIT, expecting ~$25M in annual G&A savings. The company is soliciting stockholder votes on the GOLD proxy card against a competing slate from Brancous LP1 (blue proxy card).
▲ Likely positive · significance 72 · 8-K Agent
8-K ClearSign Technologies Corp
ClearSign commissioned a 26-burner process burner installation for a petrochemical customer on the Texas Gulf Coast; internal testing indicates emissions will meet guaranteed limits, with formal NOx measurement expected within one week. The company secured 5 M1 Series midstream burner orders in Q3 and 2 additional orders in Q4 to date, all from the Permian Basin region at ~$180k per burner. Q3 2026 revenue was $712k (down from $1M YoY due to product mix), but gross margin improved to 55.6% from 35.8% due to a licensing arrangement. Cash position: $10.3M; shares outstanding: 6.81M. The company also received DOE Industrial Technology Validation Program selection with Kern Energy for a Gen2 burner installation valued at ~$500k–$750k.
▲ Likely positive · significance 72 · 8-K Agent
8-K Valor Energy Inc
On November 17, 2026, Valor Energy Inc. completed acquisition of 100% equity interests in Glorious Star LLC from Ke Gao for $3,600,000 total ($360,000 paid Nov 3; $3,240,000 at closing). The asset is a 30,888 sq ft computing facility in Youngstown, Ohio with 18 MVA electrical capacity. Company plans $700M total investment ($200M phase 1) to convert into AI data center, subject to financing, permits, and feasibility studies.
▲ Likely positive · significance 72 · 8-K Agent
F-1 PHAOS TECHNOLOGY HOLDINGS
On September 28, 2026, Phaos Technology Holdings (Cayman) Limited entered into a Securities Purchase Agreement with High West Partners LLC under which High West commits to purchase up to $10,000,000 of Class A Ordinary Shares at Phaos's discretion over 36 months. High West receives 41,322 Commitment Shares (valued at $100,000) immediately and may purchase additional shares via Single Day or VWAP purchases. Phaos pays $15,000 in High West legal fees. This F-1 registration enables High West to resell up to 406,808 Class A shares.
▲ Likely positive · significance 72 · Registration Agent
8-K Co-Diagnostics, Inc.
Co-Diagnostics Inc. issued a Senior Secured Convertible Note to J.J. Astor Co. (a Utah corporation) on November 18, 2026. Net funding: $960,000 (after $40,000 origination fee); original principal amount: $1,350,000 (including $350,000 original issue discount). Repayment: 30 weekly installments of $45,000 each through June 16, 2027. The note is convertible into common stock at a floor price of 20% of the Nasdaq Minimum Price, subject to a 9.99% (expandable to 19.99%) beneficial ownership cap. Repayment can be satisfied via ATM equity sales proceeds or conversion into registered shares.
▼ Likely negative · significance 72 · 8-K Agent
8-K BioCardia, Inc.
BioCardia (market cap ~$9.7M) filed an 8-K on November 20, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The filing provides no specific details on which exchange rule was violated, the timeline for delisting, or which exchange it may transfer to. This is a material governance event for a micro-cap company but lacks concrete financial or operational specifics in the extracted text.
▼ Likely negative · significance 72 · 8-K Agent
SCHEDULE 13D/A Hyperscale Data, Inc.
Alpha Structured Finance LP sold 19,884 Class A shares (11/17–11/18/2026) at $0.6930–$0.7347 per share; Ault Lending LLC sold 20,107 shares at $0.6069–$0.9360; Milton C. Ault III sold 1,000 shares at $0.91. Total ~40K shares sold over one week; share price deteriorated from $0.91 to $0.61, representing ~33% decline. This filing reveals coordinated insider liquidation during a sharp stock drawdown.
▼ Likely negative · significance 72 · Ownership Agent
8-K Uniti Group Inc.
Uniti Group Inc. issued $1,000,000,000 of additional 8.625% Senior Notes due June 15, 2032, as Additional Notes under an existing indenture dated June 24, 2025. These new notes are pari passu with the initial $600,000,000 of notes issued in June 2026, treating both tranches as a single series. The notes are issued by Uniti Services LLC, Uniti Fiber Holdings Inc., Uniti Group Finance 2019 Inc., and CSL Capital, LLC, with guarantees from approximately 80+ subsidiary entities.
▼ Likely negative · significance 72 · 8-K Agent
8-K Apimeds Pharmaceuticals US, Inc.
On November 12, 2026, Apimeds amended its August 19, 2026 Apitox rights assignment agreement with FreeT Inc. (South Korea). Consideration structure: (1) Initial Shares: 350,000 common shares (par $0.001), due by December 1, 2026; (2) Additional Consideration: contingent on third-party valuation — if final valuation exceeds the initial share value, Apimeds pays the excess in cash or stock within 30 days; if valuation equals or falls below initial value, no additional payment due. Valuation process: independent appraiser jointly appointed within 60 days, delivers report within 60 days thereafter. Shares are unregistered, restricted securities under Rule 144.
— Neutral · significance 72 · 8-K Agent
8-K/A National CineMedia, Inc.
On September 18, 2026, National CineMedia, Inc. (via subsidiary NCM Holdings, LLC) completed acquisition of Captivate Holdings, LLC for $275.0 million enterprise value in cash, acquiring 100% of Captivate's equity. Captivate operates a digital place-based advertising network in elevators and building lobbies across US, Canada, and France, generating $63.9M revenue in 2025. The deal was financed via $275M term loan and $10M revolver under a new 2026 Credit Agreement. Pro forma combined 2025 revenues would be $307.1M; combined company generates $29.1M revenue in first half 2026 (Captivate portion).
▲ Likely positive · significance 72 · 8-K Agent
8-K RTB Digital, Inc.
RTB Digital entered into an employment agreement with Bill Sornsin as Chief Operating Officer effective November 17, 2026, with retroactive compensation to June 1, 2026. Compensation includes: base salary of $360,000 annually; eligibility for annual bonuses under company programs; 305,000 restricted stock units (RSUs) vesting over approximately two years (1/3 on January 1, 2027, then 2/3 quarterly over seven quarters); and 100% employer-paid health insurance for employee and dependents. Severance upon termination without cause includes six months of base salary, six months of COBRA contributions, and full acceleration of all unvested equity awards.
▲ Likely positive · significance 72 · 8-K Agent
8-K TruGolf Holdings, Inc.
TruGolf completed acquisition of Canadian fintech Polymath Research on October 8, 2026, issuing 257,494 Class A common shares and 136,956 Series C preferred shares to Polymath shareholders. Q3 2026 revenue grew 29.4% to $5.3M vs. $4.1M in Q3 2025; nine-month revenue up 16.8% to $16.1M. However, net loss improved to $2.1M for Q3 2026 vs. $7.3M in Q3 2025, though gross margin compressed to 51.3% from 68.0%. Company reported working capital deficit of $3.6M as of September 30, 2026 (vs. $1.1M surplus December 31, 2025) and cash declined $7.6M to $5.0M, with substantial doubt about going-concern raised.
— Neutral · significance 72 · 8-K Agent
8-K SUNation Energy, Inc.
SUNation Energy reported Q3 2026 revenue of $11.2M (down 41% YoY from $19.0M), with net loss of $11.8M including $9.8M non-cash goodwill and intangible asset impairment charges. The company ended September 30, 2026 with $2.79M cash and a $5.35M working capital deficit (versus positive $1.07M at year-end 2025). SUNation amended its merger agreement with Suniva on September 4, 2026, targeting Q1 2027 close, requiring stockholder approval to increase authorized shares from 1.0B to 1.5B and contingent conversion of ~$2.61M related-party debt at $2.26/share.
▼ Likely negative · significance 72 · 8-K Agent
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.